Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine: Page 75
SNMMI: Fluciclovine-PET changes prostate treatment
By
Wayne Forrest
PHILADELPHIA - With the addition of F-18 fluciclovine to PET/CT scans, clinicians changed the treatment regimen for a majority of men with recurrent prostate cancer and located previously undetected lesions in a new study, which was presented on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
June 25, 2018
FluoroPharma, Ground Fluor partner on MFBG agent
By
AuntMinnie.com staff writers
Radiopharmaceutical developer FluoroPharma Medical has acquired an exclusive option to license the meta-fluorobenzylguanidine (MFBG) imaging agent from Ground Fluor Pharmaceuticals.
June 25, 2018
SNMMI: Molecular imaging method monitors gene therapy
By
AuntMinnie.com staff writers
PHILADELPHIA - A new molecular imaging method can monitor the level and location of gene expression everywhere in the brain, enabling early assessment of gene therapy for brain disease, according to findings presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
June 25, 2018
Live from SNMMI 2018: Nuclear medicine appropriate use
What's the best way to promote appropriate use of nuclear medicine? Dr. Sukhjeet Ahuja, director of evidence and quality at the Society of Nuclear Medicine and Molecular Imaging (SNMMI), spoke with Features Editor Wayne Forrest during this week’s SNMMI annual meeting about how appropriate use criteria are developed and how clinicians should proceed.
June 24, 2018
Live from SNMMI 2018: Securing the molybdenum supply
Global efforts are underway to ensure that adequate supplies of molybdenum-99 can match demand for nuclear medicine scans. Jim Harvey, PhD, of NorthStar Medical Radioisotopes spoke with Features Editor Wayne Forrest during this week’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting about the worldwide collaborative initiative.
June 24, 2018
SNMMI: AI can predict survival in sarcoma patients
By
Erik L. Ridley
PHILADELPHIA - Artificial intelligence (AI) algorithms can help predict disease-free survival in patients with soft-tissue sarcoma, according to research presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 24, 2018
GE releases new systems, software at SNMMI 2018
By
AuntMinnie.com staff writers
GE Healthcare unveiled new molecular imaging systems and software at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 conference.
June 24, 2018
SNMMI announces new officers for 2018-2019
By
AuntMinnie.com staff writers
PHILADELPHIA - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has introduced its new slate of officers for 2018-2019.
June 24, 2018
SNMMI: New therapy aids patients with neuroendocrine tumors
By
Wayne Forrest
PHILADELPHIA - Researchers from the U.S. and China are reporting early success with a new, long-lasting theranostic radionuclide therapy for patients with advanced metastatic neuroendocrine tumors. Study results were presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.
June 24, 2018
SNMMI: AI can avoid patient misidentification on PET/CT
By
Erik L. Ridley
PHILADELPHIA - Artificial intelligence (AI) software can accurately predict a patient's gender on PET/CT scans, a capability that could help to avoid patient identification errors in PACS, according to research presented on Saturday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 24, 2018
ImaginAb names new directors for Japanese subsidiary
By
AuntMinnie.com staff writers
Imaging agent developer ImaginAb has appointed a new management team for its subsidiary in Japan, ImaginAb Japan KK.
June 21, 2018
SNMMI 2018: A year of promotion and ongoing challenges
By
Wayne Forrest
The upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Philadelphia will mark the end of President Dr. Bennett Greenspan's one-year term.
AuntMinnie.com
recently spoke with Greenspan to hear his thoughts on the current state of nuclear medicine and SNMMI's path to the future.
June 21, 2018
Previous Page
Page 75 of 438
Next Page